Celldex Therapeutics Inc · Operating Cash Flow (Statement)

Latest reported-$235.57Mperiod endingJun 30, 2026

CLDX Cash from Operations ($12.30M → -$235.57M)

Annual operating cash flow (statement)

High-resolution chart · PNG

CLDX operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Celldex Therapeutics Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Dec 31, 2025	-210,945,000
Dec 31, 2024	-157,778,000
Dec 31, 2023	-107,291,000
Dec 31, 2022	-103,732,000
Dec 31, 2021	-60,909,000
Dec 31, 2020	-40,404,000
Dec 31, 2019	-46,415,000
Dec 31, 2018	-75,235,000
Dec 31, 2017	-99,931,000
Dec 31, 2016	-113,036,000
Dec 31, 2015	-98,887,000
Dec 31, 2014	-101,537,000
Dec 31, 2013	-67,669,000
Dec 31, 2012	-49,782,000
Dec 31, 2011	-35,658,000
Dec 31, 2010	-30,372,000
Dec 31, 2009	-29,869,000
Dec 31, 2008	18,280,766
Dec 31, 2007	-19,302,986
Dec 31, 2006	27,000,319
Dec 31, 2005	-6,016,630
Dec 31, 2004	-10,347,900
Dec 31, 2003	-11,739,400
Dec 31, 2002	-16,659,400
Dec 31, 2001	-20,825,500
Dec 31, 2000	-4,431,900
Dec 31, 1999	-8,539,100
Dec 31, 1998	-8,900,000
Dec 31, 1997	-7,700,000
Dec 31, 1996	-9,700,000
Dec 31, 1995	-7,900,000
Dec 31, 1994	-9,100,000
Dec 31, 1993	-5,500,000
Dec 31, 1992	-3,900,000
Apr 30, 1992	-3,000,000
Apr 30, 1990	-700,000
Apr 30, 1989	-700,000
Apr 30, 1988	0
Apr 30, 1987	12,300,000